These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16739759)

  • 1. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals.
    Snella KA; Canales AE; Irons BK; Sleeper-Irons RB; Villarreal MC; Levi-Derrick VE; Greene RS; Jolly JL; Nelson AA
    J Am Pharm Assoc (2003); 2006; 46(3):370-7. PubMed ID: 16739759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand.
    Pongwecharak J; Treeranurat T
    J Am Pharm Assoc (2003); 2011; 51(6):719-26. PubMed ID: 22068193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist-led screening program for an inner-city pediatric population.
    Elliott JP; Harrison C; Konopka C; Wood J; Marcotullio N; Lunney P; Skoner D; Gentile D
    J Am Pharm Assoc (2003); 2015; 55(4):413-8. PubMed ID: 26117001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients at risk of cardiovascular disease: a pharmacist-managed screening event for union workers and their dependents.
    Liu Y; McDonough RP; Carruthers KM; Doucette WR
    J Am Pharm Assoc (2003); 2009; 49(4):549-53. PubMed ID: 19589768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
    Bunting BA; Smith BH; Sutherland SE
    J Am Pharm Assoc (2003); 2008; 48(1):23-31. PubMed ID: 18192127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low uptake of hypertension care after community hypertension screening events in Lagos, Nigeria.
    Nelissen HE; Okwor TJ; Khalidson O; Osibogun A; Van't Hoog AH
    Glob Health Action; 2018; 11(1):1548006. PubMed ID: 30474518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care screenings at the University of Minnesota: mechanism for civic engagement.
    Palombi LC; Bastianelli K; Stratton T
    J Am Pharm Assoc (2003); 2014; 54(1):56-62. PubMed ID: 24407741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
    Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
    JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential screening for diabetes--evaluation of a campaign in Swiss community pharmacies.
    Hersberger KE; Botomino A; Mancini M; Bruppacher R
    Pharm World Sci; 2006 Jun; 28(3):171-9. PubMed ID: 17004016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American population.
    Lai LL
    Consult Pharm; 2007 May; 22(5):411-6. PubMed ID: 17658958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program.
    Fera T; Bluml BM; Ellis WM; Schaller CW; Garrett DG
    J Am Pharm Assoc (2003); 2008; 48(2):181-190. PubMed ID: 18359731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.
    Martínez-Mardones F; Fernandez-Llimos F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; S Tonin F; Garcia-Cardenas V
    J Am Heart Assoc; 2019 Nov; 8(22):e013627. PubMed ID: 31711390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes.
    Harris MI
    Diabetes Care; 2001 Mar; 24(3):454-9. PubMed ID: 11289467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients.
    Shireman TI; Svarstad BL
    J Am Pharm Assoc (2003); 2016; 56(4):389-96. PubMed ID: 27184784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-led biometric screenings: A retrospective chart review in a community pharmacy.
    Brown SA; Wensel TM; Smith W
    Res Social Adm Pharm; 2024 Feb; 20(2):145-148. PubMed ID: 37935608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
    Tsuyuki RT; Al Hamarneh YN; Jones CA; Hemmelgarn BR
    J Am Coll Cardiol; 2016 Jun; 67(24):2846-54. PubMed ID: 27058907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of wellness coaching and monitoring services provided in a community pharmacy.
    DiDonato KL; May JR; Lindsey CC
    J Am Pharm Assoc (2003); 2013; 53(1):14-21. PubMed ID: 23636151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.